The Role Adjuvant Chemotherapy in Resected Stage 1 NSCLC with High Risk Factors: A Turkish Oncology Group Study


Eralp Y., Ak N., Yilmazbayhan D., Ozkan B., Ferhatoglu F., Demirkazik A., ...Daha Fazla

JOURNAL OF THORACIC ONCOLOGY, cilt.14, 2019 (SCI İndekslerine Giren Dergi) identifier